Receptors, Purinergic P2Y12

"Receptors, Purinergic P2Y12" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A subclass of purinergic P2Y receptors that have a preference for ADP binding and are coupled to GTP-BINDING PROTEIN ALPHA SUBUNIT, GI. The P2Y12 purinergic receptors are found in PLATELETS where they play an important role regulating PLATELET ACTIVATION.

Descriptor ID	D058925
MeSH Number(s)	D12.776.543.750.695.700.720.500.300 D12.776.543.750.720.700.720.750.300
Concept/Terms	Receptors, Purinergic P2Y12 Receptors, Purinergic P2Y12 P2Y12 Receptors, Purinergic Purinergic P2Y12 Receptors Purinergic Receptor P2Y, G-Protein Coupled, 12 Purinoceptor P2Y12 P2Y12, Purinoceptor P2Y12 Purinoceptors Purinoceptors, P2Y12 P2Y(ADP) Receptor P2Y(T) Receptor P2Y12 Purinoceptor Purinoceptor, P2Y12 Purinoceptor P2T P2T, Purinoceptor Purinergic Receptor P2Y12 P2Y12, Purinergic Receptor P2T Purinoceptor Purinoceptor, P2T

Below are MeSH descriptors whose meaning is more general than "Receptors, Purinergic P2Y12".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, G-Protein-Coupled [D12.776.543.750.695]
Receptors, Purinergic [D12.776.543.750.695.700]
Receptors, Purinergic P2 [D12.776.543.750.695.700.720]
Receptors, Purinergic P2Y [D12.776.543.750.695.700.720.500]
Receptors, Purinergic P2Y12 [D12.776.543.750.695.700.720.500.300]
Receptors, Neurotransmitter [D12.776.543.750.720]
Receptors, Purinergic [D12.776.543.750.720.700]
Receptors, Purinergic P2 [D12.776.543.750.720.700.720]
Receptors, Purinergic P2Y [D12.776.543.750.720.700.720.750]
Receptors, Purinergic P2Y12 [D12.776.543.750.720.700.720.750.300]

Below are MeSH descriptors whose meaning is related to "Receptors, Purinergic P2Y12".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Purinergic P2Y12".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Purinergic P2Y12" by people in this website by year, and whether "Receptors, Purinergic P2Y12" was a major or minor topic of these publications.

Bar chart showing 13 publications over 9 distinct years, with a maximum of 3 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2005	0	1	1
2006	0	3	3
2010	0	1	1
2011	0	2	2
2013	0	1	1
2017	0	1	1
2020	0	1	1
2022	2	0	2

Below are the most recent publications written about "Receptors, Purinergic P2Y12" by people in Profiles.

Dangelmaier C, Mauri B, Patel A, Kunapuli SP, Kostyak JC. D121 Located within the DRY Motif of P2Y12 Is Essential for P2Y12-Mediated Platelet Function. Int J Mol Sci. 2022 Sep 29; 23(19).

View in: PubMed
Ma C, Fu Q, Diggs LP, McVey JC, McCallen J, Wabitsch S, Ruf B, Brown Z, Heinrich B, Zhang Q, Rosato U, Wang S, Cui L, Berzofsky JA, Kleiner DE, Bosco DB, Wu LJ, Lai CW, Rotman Y, Xie C, Korangy F, Greten TF. Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD. Cancer Cell. 2022 09 12; 40(9):986-998.e5.

View in: PubMed
Elmadany N, Logiacco F, Buonfiglioli A, Haage VC, Wright-Jin EC, Schattenberg A, Papawassiliou RM, Kettenmann H, Semtner M, Gutmann DH. Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects. Neurobiol Dis. 2020 10; 144:105030.

View in: PubMed
Schmidt RA, Morrell CN, Ling FS, Simlote P, Fernandez G, Rich DQ, Adler D, Gervase J, Cameron SJ. The platelet phenotype in patients with ST-segment elevation myocardial infarction is different from non-ST-segment elevation myocardial infarction. Transl Res. 2018 05; 195:1-12.

View in: PubMed
Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, Diamond SL, Brass LF. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood. 2013 Mar 07; 121(10):1875-85.

View in: PubMed
Stefanini L, Boulaftali Y, Ouellette TD, Holinstat M, Désiré L, Leblond B, Andre P, Conley PB, Bergmeier W. Rap1-Rac1 circuits potentiate platelet activation. Arterioscler Thromb Vasc Biol. 2012 Feb; 32(2):434-41.

View in: PubMed
Stolla M, Stefanini L, André P, Ouellette TD, Reilly MP, McKenzie SE, Bergmeier W. CalDAG-GEFI deficiency protects mice in a novel model of Fc? RIIA-mediated thrombosis and thrombocytopenia. Blood. 2011 Jul 28; 118(4):1113-20.

View in: PubMed
Campbell PG, Sen A, Yadla S, Jabbour P, Jallo J. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. World Neurosurg. 2010 Aug-Sep; 74(2-3):279-85.

View in: PubMed
Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW. Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic. 2006 Oct; 7(10):1420-31.

View in: PubMed
Holinstat M, Voss B, Bilodeau ML, McLaughlin JN, Cleator J, Hamm HE. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J Biol Chem. 2006 Sep 8; 281(36):26665-74.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement